10 research outputs found

    Een jongen met een pijnlijke knie

    Get PDF

    No difference in 1-year improvement of patient-reported physical functioning and pain between resurfaced and unresurfaced patellae: analysis of 17,224 primary total knee arthroplasties in the Dutch Arthroplasty Register

    Get PDF
    Background and purpose - Whether or not to resurface the patella during primary total knee arthroplasty (TKA) remains controversial. We aimed to investigate the asso-ciation between patellar resurfacing and patient-reported outcome measure (PROM) improvement 1 year postopera-tively in terms of physical functioning and pain following TKA. Patients and methods - We performed an observa-tional study using the Dutch Arthroplasty Register on pro-spectively collected PROM data (n = 17,224, years 2014- 2019). Preoperative and 1-year PROM pain scores (NRS at rest; during activity) and physical functioning scores (KOOS-PS, OKS) were examined. Stratification was per-formed for cruciate-retaining (CR) and posterior-stabilized (PS) and for the 4 most frequently used TKA implants in the Netherlands (Nexgen, Genesis II, PFC/Sigma, Vanguard) using multivariable linear regression adjusting for age, ASA classification, preoperative general health (EQ VAS), and preoperative PROMs. Results - 4,525 resurfaced and 12,699 unresurfaced patellae in TKA were analyzed. Overall, no significant differ-ence in 1-year PROM improvement was found between the 2 groups. In CR TKAs, resurfacing resulted in less improve-ment in KOOS-PS and OKS (adjusted difference between groups (B) -1.68, 95% confidence interval (CI) -2.86 to -0.50 and B -0.94, CI -1.57 to -0.31. Fewer improvements for patellar resurfacing in TKA were found for the Genesis TKA on NRS pain at rest (B -0.23, CI-0.40 to -0.06) and Oxford knee score (B -1.61, CI -2.24 to -0.98). Conclusion - No significant differences were found in 1-year improvement of physical functioning and pain between TKA with resurfaced and unresurfaced patellae.Orthopaedics, Trauma Surgery and Rehabilitatio

    Rare primary patellar resurfacing does not lead to more secondary patellar resurfacing: analysis of 70,014 primary total knee arthroplasties in the Dutch Arthroplasty Register (LROI)

    No full text
    Background and purpose - Current literature provides no conclusive evidence in support of a patellar resurfacing vs. non-resurfacing regime. Therefore, we compared the incidence of secondary patellar resurfacing among hospitals using 3 different primary patellar resurfacing regimes in the Netherlands. Secondarily we identified patient and surgical characteristics associated with primary patellar resurfacing and secondary patella resurfacing following non-resurfaced primary total knee arthroplasty (TKA).Patients and methods - We used data from 2014-2016 of the Dutch Arthroplasty Register. Hospitals were divided into rare (0-10%), selective (>10% to 90%), and usually primary patellar resurfacing (>90%) regimes. We performed a logistic regression analysis for associated factors of primary patellar resurfacing in the selective resurfacing subgroup and for secondary patellar resurfacing in the rare resurfacing subgroup.Results - The rate of primary resurfacing was 5.2% for the rare and 36% for the selective patellar resurfacing regimes, with similar secondary patellar resurfacing (1.1% vs. 0.9%). Predictors for primary patellar resurfacing were being female (OR 1.3) and younger (50-59 years, OR 1.4). The PS prosthesis design had a higher OR (4.1) than the CR design. Younger age (50-59 years, OR 1.5) and PS prosthesis (OR 2.7) were significant predictors of secondary patellar resurfacing. Particular surgical systems have a higher rate of primary and secondary patellar resurfacing.Interpretation - Low rates of secondary patellar resurfacing in hospitals with a rare resurfacing regime indicate that this regime does not lead to more secondary patellar resurfacing then selective resurfacing. In the Dutch orthopedic community primary and secondary patellar resurfacing is associated with using a posterior stabilizing design, being younger, and using particular TKA systems

    Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1

    No full text
    Despite the high incidence of developmental dysplasia of the hip (DDH), treatment is very diverse. Therefore, the Dutch Orthopedic Society developed a clinical practice guideline with recommendations for optimal and uniform treatment of DDH. This article summarizes the guideline on centered DDH (i.e. Graf types 2A-C).The guideline development followed the criteria of Appraisal of Guidelines for Research and Evaluation II. A systematic literature review was performed to identify randomized controlled trials and comparative cohort studies including children 6 months; (3) assess patients every 6 weeks; and (4) discontinue the abduction device when the hip has normalized or when the child is 12 months.This paper presents a summary of part 1 of the first evidence-based guideline for treatment of centered DDH in children <1 year. Part 2 presents the guideline on decentered DDH in a separate article.Orthopaedics, Trauma Surgery and Rehabilitatio

    Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1

    No full text
    Despite the high incidence of developmental dysplasia of the hip (DDH), treatment is very diverse. Therefore, the Dutch Orthopedic Society developed a clinical practice guideline with recommendations for optimal and uniform treatment of DDH. This article summarizes the guideline on centered DDH (i.e. Graf types 2A-C).The guideline development followed the criteria of Appraisal of Guidelines for Research and Evaluation II. A systematic literature review was performed to identify randomized controlled trials and comparative cohort studies including children 6 months; (3) assess patients every 6 weeks; and (4) discontinue the abduction device when the hip has normalized or when the child is 12 months.This paper presents a summary of part 1 of the first evidence-based guideline for treatment of centered DDH in children <1 year. Part 2 presents the guideline on decentered DDH in a separate article
    corecore